REGN•benzinga•February 24, 2025 at 08:01 PM

Regeneron Pharmaceuticals Presents Latest DB-OTO Results, Says Demonstrate Clinically Meaningful Hearing Improvements In Nearly All Children With Profound Genetic Hearing Loss In CHORD Trial; As Presented At ARO, 10 Of 11 Children With At Least One Post-T

No summary available.

Read the full article from the original source for complete details and context.

Article published on February 24, 2025 by benzinga